Heart Test Laboratories, Inc.
General ticker "HSCS" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $3.9M (TTM average)
Heart Test Laboratories, Inc. follows the US Stock Market performance with the rate: 5.2%.
Estimated limits based on current volatility of 3.7%: low 2.43$, high 2.61$
Factors to consider:
- Earnings expected soon, date: 2025-12-15 bmo
- Total employees count: 15 (+25.0%) as of 2024
- Top business risk factors: Regulatory and compliance, Operational and conduct risks, Third-party risks, Market competition, Software reliability
- Price in estimated range
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-04-30 to 2027-04-30
- 2025-04-30 to 2026-04-30 estimated range: [1.84$, 6.70$]
- 2026-04-30 to 2027-04-30 estimated range: [1.24$, 4.82$]
Financial Metrics affecting the HSCS estimates:
- Positive: with PPE of -0.4 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -236.82 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
Short-term HSCS quotes
Long-term HSCS plot with estimates
Financial data
| YTD | 2023-04-30 | 2024-04-30 | 2025-04-30 |
|---|---|---|---|
| Operating Revenue | $0.01MM | $0.02MM | $0.00MM |
| Operating Expenses | $6.12MM | $6.32MM | $8.36MM |
| Operating Income | $-6.11MM | $-6.31MM | $-8.35MM |
| Non-Operating Income | $-0.24MM | $-0.30MM | $-0.41MM |
| Interest Expense | $0.24MM | $0.35MM | $0.50MM |
| R&D Expense | $2.46MM | $2.88MM | $4.39MM |
| Income(Loss) | $-6.35MM | $-6.61MM | $-8.77MM |
| Profit(Loss)* | $-490.85MM | $-6.61MM | $-8.77MM |
| Stockholders Equity | $0.23MM | $7.32MM | $0.21MM |
| Inventory | $0.68MM | $0.63MM | $0.65MM |
| Assets | $3.29MM | $9.50MM | $4.22MM |
| Operating Cash Flow | $-5.77MM | $-6.07MM | $-7.41MM |
| Capital expenditure | $0.02MM | $0.13MM | $0.03MM |
| Investing Cash Flow | $-0.02MM | $-0.13MM | $-0.03MM |
| Financing Cash Flow | $6.53MM | $10.34MM | $2.73MM |
| Earnings Per Share** | $-6,173.88 | $-18.74 | $-9.34 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.